Taiwan FDA registration 96a13d3bb45ec833828127ba3d794fca
BIOPORT PLUS 1.5% Intra-articular Injection
TW: 百優玻關節內注射劑
Taiwan·Risk Class 3·MD·MAXIGEN BIOTECH INC.·Registered Jul 26, 2022 – Jun 30, 2028ActiveRegistration details
- Analysis ID
- 96a13d3bb45ec833828127ba3d794fca
- License Form
- Ministry of Health Medical Device Manufacturing No. 007514
Company information
- Manufacturer
- MAXIGEN BIOTECH INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- MAXIGEN BIOTECH INC.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- N Orthopedics
- Product Type (Level 2)
- N0003 Hyaluronic acid implants for the joint cavity
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jul 26, 2022
- Expiry Date
- Jun 30, 2028
About this record
Access comprehensive regulatory information for BIOPORT PLUS 1.5% Intra-articular Injection in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 96a13d3bb45ec833828127ba3d794fca and manufactured by MAXIGEN BIOTECH INC.. The authorized representative in Taiwan is MAXIGEN BIOTECH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices